Wiktionary
lumiliximab
n. A chimeric monoclonal antibody being investigated for the treatment of chronic lymphocytic leukemia.
Wikipedia
Lumiliximab
Lumiliximab is a monoclonal antibody that targets CD23. It acts as an immunomodulator and, , it is being investigated in Phase I and II clinical trials for the treatment of chronic lymphocytic leukemia. The drug is a chimeric antibody from Macaca irus and Homo sapiens.